Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impact.

about

Hepatitis C Virus (HCV)-Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design.

P2860

Q55513556-BD55CB76-9560-4099-86C6-106A23434AD0

P2860

Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impact.

Item

http://www.wikidata.org/entity/Q39380623

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impact.

@en

Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impact.

@nl

type

Item

label

Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impact.

@en

Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impact.

@nl

prefLabel

Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impact.

@en

Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impact.

@nl

P1476

Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impact

@en

P2093

Emilie Crouchet

http://www.w3.org/2001/XMLSchema#string

Thomas F Baumert

http://www.w3.org/2001/XMLSchema#string

P2860

Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains

The C-terminal lipid-binding domain of apolipoprotein E is a highly efficient mediator of ABCA1-dependent cholesterol efflux that promotes the assembly of high-density lipoproteins

Apolipoprotein E likely contributes to a maturation step of infectious hepatitis C virus particles and interacts with viral envelope glycoproteins

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I

Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders

Hepatitis C virus relies on lipoproteins for its life cycle

Mechanisms of Hepatitis C Viral Resistance to Direct Acting Antivirals

Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection

P304

593-606

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14789450.2017.1344102

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Catherine Schuster

P577

2017-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28625086

http://www.w3.org/2001/XMLSchema#string

P932

6138823

http://www.w3.org/2001/XMLSchema#string

Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impact.

about

P2860

P2860

Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impact.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932